ABSTRACT -Background -Low bone mineral density is considered an extra-intestinal manifestation of celiac disease with reduced bone mass, increased bone fragility, and risk of fractures. Celiac disease is considered a condition at high risk for secondary osteoporosis and the evaluation of bone density is very important in the clinical management of these patients. Objective -The present study aimed to investigate bone alterations in celiac patients from Curitiba, South Region of Brazil at diagnosis, correlating the findings with age and gender. Methods -Patients who were included in the study were attended to in a private office of the same physician from January 2009 to December 2013. The diagnosis of celiac disease was done through clinical, serological and histological findings. All data were collected from the medical charts of the patients. After the diagnosis of celiac disease, evaluation for low bone mineral density was requested by dual-energy X-ray absorptiometry (DEXA). DEXA bone densitometer was used to estimate low bone mineral density at the lumbar spine and femur. Results -A total of 101 patients, 82 (81.2%) female and 19 (18.8%) male subjects, with mean age of 39.0±3.03 years were included. At celiac disease diagnosis, 36 (35.6%) were younger than 30 years, 41 (40.6%) were between 31 and 50 years, and 24 (23.8%) were older than 50 years. Among the evaluated patients, 69 (68.3%) presented low bone mineral density, being 47% with osteopenia and 32% with osteoporosis. Patients who were older than 51 years and diagnosed with celiac disease presented low bone mineral density in 83.3% (20/24) of the cases. As expected, age influenced significantly the low bone mineral density findings. Among women, low bone mineral density was present with high frequency (60%) from 30 to 50 years. In patients diagnosed older than 60 years (n=8), all the women (n=5) and two of the three men had osteoporosis. Conclusion -This study demonstrated that 69% of Brazilian patients with celiac disease at diagnosis had low bone mineral density, being more frequent in women older than 50 years. HEADINGS -Celiac disease. Osteoporosis. Metabolic bone diseases. Densitometry
INTRODUCTION
The clinical picture of celiac disease (CD) is highly variable, in which the immune response is mainly targeted to the intestinal mucosa; however, it can affect any organ or tissue. Low bone mineral density (BMD) is considered an extra-intestinal manifestation of CD with reduced bone mass, increased bone fragility, and risk of fractures (6) . CD is considered a condition at high risk for secondary osteoporosis, and the evaluation of bone density is very important in the clinical management of these patients. Nevertheless, studies investigating the prevalence of bone derangement in patients with CD are still inconclusive because both old and recent findings are widely incongruous (4) .
LOW BONE MINERAL DENSITY IN BRAZILIAN PATIENTS AT DIAGNOSIS OF CELIAC DISEASE
Intestinal malabsorption and inflammation contribute to the pathophysiology of bone damage in CD. Villous atrophy is responsible for alterations of intestinal absorption, and a negative calcium balance was shown in CD patients because of several mechanisms: malabsorption of calcium in untreated patients (9) , partially reversible after gluten-free diet (GFD) (12) ; the reduction of calcium intake (5) also because of a secondary lactose intolerance; and the reduction of intestinal calcium absorption because of its binding to intraluminal unabsorbed fatty acids (9) . Also, vitamin D deficiency is known to be common among patients with CD, although there are no changes in the expression of vitamin D receptors (1) . Because of the increased prevalence of osteoporosis, celiac patients DOI: 10.1590/S0004-28032015000300004 have a high risk of fracture, estimated between 3.5 and 7 times higher than that of the unaffected population of the same age and gender (14) . The present study aimed to investigate bone alterations in celiac patients from Curitiba, South Region of Brazil at diagnosis, correlating the findings with age and gender.
METHODS
This study was approved by the local Ethics in Research Committee (Pontifical Catholic University). Patients who were included in the study were attended to in a private office of the same physician from January 2009 to December 2013. The diagnosis of CD was done through clinical, serological (IgA antiendomysium), and histological findings (Marsh classification) according to World Gastroenterology Organization (16) . All data were collected from the medical charts of the patients. After the diagnosis of CD, evaluation for BMD was requested by dual-energy X-ray absorptiometry (DEXA). DEXA bone densitometer was used to estimate BMD at the lumbar spine and femur. An X-ray tube and detector scanned over the area of interest and generated an image of bone mineral content expressed in grams of calcium. Built-in software identified the projected bone area using an edge detection algorithm. Dividing bone mineral content by bone area gave the BMD. This value was compared with that of BMD of young population, and the result was expressed as T score. WHO criteria were used to define BMD as normal (T score, >-1), osteopenia (T score, -1 to -2.5), osteoporosis (T score, <-2.5), and severe osteoporosis (fragility fractures; T score, <-2.5) (15) . Frequency data were analyzed in percentages. Values were expressed in mean and standard deviation. Comparison of nominal data was done using analysis of variance and Fisher test. Significance adopted was of 5%. Statistical tests were calculated with the help of the software Graph Pad Prism 5.0.
RESULTS
A total of 101 patients, 82 (81.2%) female and 19 (18.8%) male subjects, with mean age of 39.0±3.03 years were included in the investigation. At CD diagnosis, 36 (35.6%) were younger than 30 years, 41 (40.6%) were between 31 and 50 years, and 24 (23.8%) were older than 50 years.
BMD evaluated by DEXA in femur and spinal cord was demonstrated in Table 1 and Figure 1 . Among the evaluated patients, 69 (68.3%) presented low BMD, being 47% with osteopenia and 32% with osteoporosis. Bone alterations were observed in the young group, wherein three patients were younger than 30 years; one of them was a 19-year-old male patient, presented osteoporosis. Patients who were older than 51 years and diagnosed with celiac disease presented low BMD in 83.3% (20/24) of the cases. As expected, age influenced significantly the BMD findings. Table 2 shows the results of DEXA according to gender. Among women, BMD was present with high frequency (60%) from 30 to 50 years. In patients diagnosed older than 60 years (n=8), all the women (n=5) and 2 of the 3 men had osteoporosis. Two women (51 and 53 years) with previous diagnosis of CD had fracture history.
DISCUSSION
This study evaluated and showed high prevalence of low BMD in Brazilian patients with CD at diagnosis. Also, osteopenia and osteoporosis were found at an early age in celiac patients at diagnosis.
Recently, Gusso et al. (3) studied 100 consecutive male and female patients with osteoporosis (convenience sample) who were treated in a single tertiary center at South Brazil. Only one patient was diagnosed with CD and referred minor gastrointestinal complaints. The authors found low rate of patients with CD in this group. On the other hand, the present study found that 69% of the CD patients at diagnosis had low BMD, showing that this is a frequent finding in CD regardless of the clinical presentation. The prevalence of low BMD in untreated celiac disease is reported to be 38% to 72% in different populations (8) . Among them, the prevalence of osteoporosis is at least twice that of the unaffected population in the same age range (13) . Bone alterations were thought to result in intestinal malabsorption and steatorrhea; however, currently, a more complex interaction between cytokines and local/systemic factors influencing bone formation and reabsorption is envisaged (7) . Osteotropic cytokines are involved in bone remodeling because they regulate the differentiation and activation of costeoblasts and osteoclasts. In inflammatory diseases, including CD, the chronic release of proinflammatory cytokines is well known. Pathogenesis of bone derangement in patients with CD need to be clearly established, and other mechanisms should be investigated. Other research has demonstrated the association between a genetic predisposition (IL-1 gene) and low bone mass in patients with CD (10) . Additionally, calcium supply in the diet of patients with CD is reduced even more because of a decreased intake of milk and dairy products in an effort to avoid lactose. Secondary lactose intolerance resulting from decreased lactase production by the damaged villi is common in patients with CD (5) . Low BMD is described in both asymptomatic and symptomatic CD patients. Worrying is the situation of patients with asymptomatic or silent CD because anemia and vitamin D alterations show a very high prevalence also in this subgroup (2) . Considering the prevalence of bone loss in patients with and without overt malabsorption symptoms, BMD measurement could provide more important information in asymptomatic than in clinically overt malabsorber patients. Moreover, the most important risk factor at diagnosis seems to be the age of the patient. Olmos et al. (11) , in a meta-analysis about fracture risk, which included 21,000 celiac patients and about 100,000 controls, confirmed a 43% increase in the prevalence of fractures among celiac (8.7% vs. 6.1%). In our study, two patients attended had fracture history and previous CD diagnosis.
In general population, low BMD was associated with gender, being more prevalent in female subjects. The same occurred in CD; however, as demonstrated in the present study, osteopenia and osteoporosis can appear early in younger male subjects. In celiac patients diagnosed after 50 years old, both women and men presented low BMD. Bone disease is known to be a multifactorial illness, and other factors, such as hormones, smoking, and physical activity, also have great influence.
A strict gluten-free diet is thought to be the only effective treatment for CD; however, currently, a question of whether GFD alone is an effective treatment to correct bone alterations in patients with CD is under debate (7) . Concluding, this study demonstrated that 69% of Brazilian patients with CD at diagnosis had bone alterations in all ages, mainly osteopenia. The authors recommend bone evaluation in all patients diagnosed with CD, aiming precocious detection and treatment of these diseases.
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